Corrected Version: Sodium Benzoate, A Metabolite of Cinnamon and A Food Additive, Improves Cognitive Functions in Mice After Controlled Cortical Impact Injury
Journal of Clinical & Experimental Immunology · 30.03.2026 · 11 (01) · 01-16
DOI: 10.33140/jcei.11.01.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Experimental Immunology, online erschienen am 30.03.2026. Verfasst von Suresh B Rangasamy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a major health concern, sometimes leading to long-term neurological disability, especially in children, young adults, and war veterans. Although the research investigators and clinicians have applied different treatment strategies or neurosurgical procedures to solve this health issue, we are still in need of effective therapy to halt the pathogenesis of brain injury. Earlier we have reported that sodium benzoate (NaB), a metabolite of cinnamon and a Food and Drug Administration-approved drug against urea cycle disorders and glycine encephalopathy, protects neurons in animal models of Parkinson’s disease and Alzheimer’s disease. This study was undertaken to examine the therapeutic efficacy of NaB in controlled cortical impact (CCI)-induced preclinical mouse model of TBI. Oral treatment with NaB, but not sodium formate (NaFO), was found to decrease the activation of microglia and astrocytes and inhibits the expression of inducible nitric oxide synthase (iNOS) in hippocampus and cortex of CCI-insulted mice. Further, administration of NaB also reduced the vascular damage and decreased the size of lesion cavity in the brain of CCIinduced mice. Importantly, NaB-treated mice showed significant improvements in memory and locomotor functions as well as displayed substantial reduction in depression like behaviors. These results delineate a novel neuroprotective property of NaB, highlighting its possible therapeutic importance in TBI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, USA.
- Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.
Förderung
- BLRD VA
Zitieren
APA
Rangasamy, S. B., Raha, S., Dasarathi, S., & Pahan, K. (2026). Corrected Version: Sodium Benzoate, A Metabolite of Cinnamon and A Food Additive, Improves Cognitive Functions in Mice After Controlled Cortical Impact Injury. Journal of Clinical & Experimental Immunology, 11(01), 01-16. https://doi.org/10.33140/jcei.11.01.03
Vancouver
Rangasamy SB, Raha S, Dasarathi S, Pahan K. Corrected Version: Sodium Benzoate, A Metabolite of Cinnamon and A Food Additive, Improves Cognitive Functions in Mice After Controlled Cortical Impact Injury. Journal of Clinical & Experimental Immunology. 2026;11(01):01-16. doi:10.33140/jcei.11.01.03
BibTeX
@article{Rangasamy2026,
author = {Rangasamy, Suresh B and Raha, Sumita and Dasarathi, Sridevi and Pahan, Kalipada},
title = {Corrected Version: Sodium Benzoate, A Metabolite of Cinnamon and A Food Additive, Improves Cognitive Functions in Mice After Controlled Cortical Impact Injury},
journal = {Journal of Clinical & Experimental Immunology},
year = {2026},
volume = {11},
number = {01},
pages = {01--16},
doi = {10.33140/jcei.11.01.03}
}
EUVIMED